References
1-Hauser RG, Casey SA, Gitter CB, et al. Reliability and longevity of implantable defibrillators. J Interv Card Electrophysiol (2021). https://doi.org/10.1007/s10840-020-00920-w.
2- Boriani G, Merino J, Wright DW, Gadler F, Schaer B, Landolina M. Battery longevity of implantable cardioverter-defibrillators and cardiac resynchronization therapy defibrillators: technical, clinical and economic aspects. An expert review paper from EHRA. Europace 2018; 20: 1882-1897.
3-Ip, J. Premature battery depletion of EMBLEM subcutaneous implantable cardioverter-defibrillators (S-ICD). J Cardiovasc Electrophysiol 2021; _______.
4- Naughton A. December 2020 EMBLEM S-ICD accelerated battery depletion physician letter. Available at https://www.bostonscientific.com/en-US/pprc/product-advisories.html. Accessed January 25, 2021.
5-Naughton A. December 2020 EMBLEM S-ICD electrical overstress physician letter. Available at https://www.bostonscientific.com/en-US/pprc/product-advisories.html. Accessed January 25, 2021.
6- Naughton A. December 2020 model 3501 physician letter. Available at https://www.bostonscientific.com/en-US/pprc/product-advisories.html. Accessed January 25, 2021.
7- Gornick CC, Hauser RG, Almquist AK, Maron BJ. Unpredictable implantable cardioverter-defibrillator pulse generator failure due to electrical overstress causing sudden death in a young high-risk patient with hypertrophic cardiomyopathy. Heart Rhythm 2004; 2:681-683.
8-Maisel WH. Semper fidelis-Consumer protection for patients with implanted medical devices. N Engl J Med 2008; 358: 985-987.
9-Carlson MD, Wilkoff BL, Maisel WH, et al. Recommendations from the Heart Rhythm Society task force on device performance policies and guidelines. Heart Rhythm 2006; 1251-1273.